天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

ChemicalBook Chinese Germany Japanese Korean

上海一飛生物科技有限公司 Company Information
Company Name:    Shanghai Yifei Biotechnology Co. , Ltd.
Tel:    021-65675885
Email:    customer_service@efebio.com
Nationality:    China
WebSite:    http://www.efebio.com
Product List:    11974
91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120
Product List
EWP 815 20231-01-0
Eflucimibe 202340-45-2
2,4-D-d3 202480-67-9
(R)-Azasetron besylate 2025360-91-0
Ticalopride 202590-69-0
BMS-195270 202822-23-9
Morolimumab 202833-07-6
Atorolimumab 202833-08-7
XMU-MP-3 2031152-08-4
XMU-MP-2 2031152-10-8
Iscalimab 2031153-61-2
PDD00031705 2032096-45-8
IRAK4-IN-8 2033070-97-0
Levilimab 2035008-70-7
BAY 1892005 2036352-13-1
beta-Endosulfan-d4 203716-99-8
Iroxanadine 203805-20-3
Allopregnanolone-d4 203805-85-0
Vopratelimab 2039148-04-2
BI-6901 2040401-92-9
Coleneuramide 204200-47-5
Kras4B G12D-IN-1 2042365-85-3
AZ506 2043321-54-4
Abrezekimab 2043952-59-4
Tepoditamab 2044679-53-8
Seclidemstat mesylate 2044953-70-8
FD223 2050524-24-6
Ravagalimab 2050816-56-1
Avexitide acetate 2051593-46-3
Izencitinib 2051918-33-1
BTX161 2052301-24-1
Upacicalcet sodium 2052969-18-1
TNF-α-IN-9 2054199-25-4
BTM-3528 2054998-45-5
Lenvervimab 2055006-79-4
BMS-986224 2055200-88-7
Mal-amido-PEG3-NHS ester 2055353-77-8
Nesuparib 2055357-64-5
Tuvatexib 2055404-90-3
ERK-IN-3 benzenesulfonate 2055597-39-0
Mitazalimab 2055640-86-1
Claficapavir 2055732-24-4
PF-06445974 2055776-17-3
S5A1 2055882-51-2
Osocimab 2056878-75-0
WAY-239196 205749-56-0
Murlentamab 2058047-65-5
Epratuzumab 205923-57-5
Etigilimab 2044984-83-8
K67 2046250-48-8
Sutimlimab 2049079-64-1
AM-8123 2049973-02-4
Azelaprag 2049980-18-7
Cetrelimab 2050478-92-5
(Rac)-LB-100 2061038-65-9
Belantamab 2061894-48-0
Tovinontrine 2062661-53-2
Tilpisertib 2065153-41-3
Orilanolimab 2066544-85-0
PF-06843195 2067281-51-8
USP30 inhibitor 11 2067332-64-1
EGFR-IN-99 2068806-31-3
Pitavastatin D4 2070009-71-9
SR9011 hydrochloride 2070014-94-5
UNC2025 hydrochloride 2070015-17-5
MAX-40279 2070931-57-4
TBI-223 2071265-08-0
Sintilimab (anti-PD-1) 2072873-06-2
HDAC-IN-52 2075787-77-6
D-Ribose 5-phosphate disodium dihydrate 207671-46-3
CMX-521 2077178-99-3
Casein Kinase inhibitor A86 2079069-01-3
Retifanlimab 2079108-44-2
TU-2100 207972-39-2
Pumafentrine 207993-12-2
JHU395 2079938-92-2
Sirpiglenastat 2079939-05-0
GSK3494245 2080410-41-7
F13714 fumarate 208109-39-1
Quetmolimab 2084037-83-0
Tz-Thalidomide 2087490-42-2
Lingdolinurad 2088176-96-7
SM1-71 2088179-99-9
Brentuximab 2088770-90-3
Anticancer agent 7 2088956-21-0
PSB-16133 sodium 2089035-40-3
Rolusafine 2089153-78-4
Golexanolone 2089238-18-4
VT-1598 2089320-99-8
Palazestrant 2092925-89-6
OTS193320 2093401-33-1
TV 3279 209394-29-6
Prolgolimab 2093956-19-3
Cinpanemab 2094516-02-4
Posenacaftor sodium 2095064-06-3
(R)-Posenacaftor sodium 2095064-09-6
PFB-FDGlu 209540-62-5
PU-H71 HCl 2095432-24-7
GSK269962A hydrochloride 2095432-71-4
Rolinsatamab 2095467-30-2
91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120
Copyright 2007©  ChemicalBook. All rights reserved.